- Venus Concept Inc VERO announced a restructuring plan, workforce reduction, management transition, and preliminary unaudited revenue results.
- President & Chief Business Officer Hemanth Varghese was appointed to a newly created executive role, President & Chief Innovation and Business Officer.
- Related: Venus Concept Stock Surges On FDA Approval For Robotic Skin Resurfacing Tech.
- In addition to his continuing responsibilities as Chief Business Officer, Dr. Varghese will lead the company's global R&D activities.
- Søren Maor Sinay, the company's Chief Operating Officer, announced his decision to leave for personal reasons. He will continue as a Senior Advisor until March 6, 2023.
- The company's board approved the restructuring, including a reduction in its employee base by up to 70 employees, constituting a reduction of approximately 18% in the company's global workforce.
- The company estimates to incur restructuring charges of $2.0 million to $2.5 million and expects the restructuring plan to result in total annual pre-tax savings of $13-$15 million beginning in 2024.
- For Q4 FY22, Venus expects sales of $23.5-$24.5 million, down 25-28% Y/Y, versus the consensus of $25.12 million.
- For FY22, the company expects sales of $98.7-$99.7 million, down 6%-7% Y/Y, below the consensus of $100.25 million.
- Price Action: VERO shares are down 9.5% at $0.3501 on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in